Male Birth Control: The Hormonal Gel Trial

For decades, the responsibility of reliable, reversible birth control has fallen almost exclusively on women. While options like the pill, IUDs, and implants have been available for female reproductive health since the mid-20th century, men have been limited to two primary choices: condoms or a vasectomy. A groundbreaking shift is currently underway as a new transdermal gel moves through advanced testing. Known as NES/T, this hormonal gel represents the most promising development in male contraception in years and is currently undergoing Phase 2b clinical trials on an international scale.

What is the NES/T Gel?

The product at the center of this trial is a hormonal gel developed by the Population Council and the National Institute of Child Health and Human Development (NICHD). It is designed to be applied daily to the shoulders and upper arms. Unlike a pill that must pass through the digestive system, this transdermal gel is absorbed directly through the skin into the bloodstream.

The gel contains a specific combination of two hormones:

  • Segesterone Acetate (Nestorone): This is a progestin that blocks natural testosterone production in the testes, which drastically lowers sperm production to near-zero levels.
  • Testosterone: Because Nestorone halts the body’s natural production of testosterone, synthetic testosterone is added to the gel to maintain normal blood levels. This ensures that men do not experience the side effects of low testosterone, such as low libido, loss of muscle mass, or mood instability.

The goal is to suppress sperm production while keeping the man’s hormonal balance otherwise normal.

Inside the Phase 2 Clinical Trial

The current study is a Phase 2b clinical trial. In the world of pharmaceutical testing, Phase 2 is critical because it moves beyond checking for basic safety and begins to test actual effectiveness in real-world scenarios.

This trial is notable for its scope. Researchers aim to enroll over 400 couples across several countries. Participating sites include locations in the United States (such as the University of Washington and UCLA), the United Kingdom, Sweden, Italy, Chile, and Kenya. The international nature of the study helps researchers understand if the drug works consistently across different genetic backgrounds and body types.

How the Study is Structured

The trial is rigorous and requires a high level of commitment from participants. It typically involves three distinct stages:

  1. The Suppression Phase: Men apply the gel daily for 4 to 12 weeks. during this time, they continue to use other forms of birth control. Doctors monitor their sperm count regularly. The goal is to reach a concentration of fewer than 1 million sperm per milliliter.
  2. The Efficacy Phase: Once the sperm count drops low enough, the couple stops using other forms of contraception. They rely solely on the gel for pregnancy prevention for up to one year. This is the “high stakes” portion of the trial that proves whether the drug actually works.
  3. The Recovery Phase: After the year is up, the men stop using the gel. Researchers continue to monitor them to ensure their sperm production returns to normal fertility levels.

Effectiveness and Early Results

Early data and previous studies suggest the NES/T gel is highly effective. The mechanism of using progestin to shut down the signaling from the pituitary gland to the testes is well-understood science. In preliminary findings, a vast majority of participants achieved the necessary suppression of sperm production.

The threshold for effectiveness in male birth control is strictly defined. While a normal sperm count is anywhere from 15 million to over 200 million sperm per milliliter, this method aims for “azoospermia” (no sperm) or severe oligospermia (less than 1 million). At these levels, the likelihood of causing a pregnancy is statistically comparable to the failure rates of female hormonal birth control or vasectomies.

Usage and User Experience

One of the major hurdles for male birth control has been acceptability. Will men actually use it? The NES/T gel addresses this by making the application simple and non-invasive.

Participants in the trial apply about a teaspoon of the gel to their shoulders once a day. The substance dries quickly and does not require a patch or injection. The main precaution is that men must avoid skin-to-skin contact with others (specifically women and children) on the application site for about four hours after application to prevent transferring the hormones. Showering or covering the area with a shirt usually mitigates this risk.

Side Effects and Safety Profile

Because this is a hormonal treatment, side effects are a primary focus of the Phase 2 trial. The addition of replacement testosterone is meant to neutralize most negative symptoms, but the balance must be precise.

Reported side effects in early testing phases have generally been mild. They include:

  • Acne
  • Weight gain (usually minor)
  • Changes in libido (increased or decreased)
  • Mood swings

Crucially, the trial monitors for any adverse effects on cholesterol, blood pressure, and prostate health. So far, the safety profile appears favorable compared to earlier attempts at male contraception that involved injections or implants, which often caused more severe mood disruptions or injection site pain.

The Path to Market

While the Phase 2b trial is a massive step forward, a commercially available product is still several years away. If the current trials conclude successfully, the drug must move to Phase 3 trials. Phase 3 involves thousands of participants and focuses on identifying rare side effects and confirming efficacy on a larger scale.

Following Phase 3, the developers would submit the data to regulatory bodies like the FDA for approval. Realistically, if every stage proceeds without major setbacks, the NES/T gel could potentially reach the market by the late 2020s.

Frequently Asked Questions

Is the male birth control gel reversible? Yes. The effects are fully reversible. Once a man stops applying the gel, his body resumes natural testosterone and sperm production. The trial data specifically tracks how long this recovery takes, which is usually a few months.

Does the gel protect against STIs? No. Like the pill or IUDs for women, the NES/T gel is strictly for pregnancy prevention. It provides no protection against sexually transmitted infections. Condoms are still necessary for STI protection.

Why has it taken so long to get a male pill or gel? Biological complexity is a major factor. Women release one egg per month, while men produce millions of sperm daily. Stopping millions of cells is mechanically more difficult than stopping one. Additionally, the safety bar is higher for healthy men because they do not carry the physical risks of pregnancy. Therefore, regulatory agencies require an extremely low risk profile for male contraceptives.

Can I buy the gel now? No. The NES/T gel is not available for purchase. It is only available to selected participants enrolled in the clinical trials.